SENORES
Invest with MTF
Invest Now
Invest in Senores Pharmaceuticals with 3.04X leverage
Performance
- Low
- ₹758
- High
- ₹813
- 52 Week Low
- ₹440
- 52 Week High
- ₹877
- Open Price₹790
- Previous Close₹790
- Volume246,226
- 50 DMA₹798.45
- 100 DMA₹761.09
- 200 DMA₹687.98
Investment Returns
- Over 1 Month -0.09%
- Over 3 Month + 12.74%
- Over 6 Month + 29.09%
- Over 1 Year + 53.4%
Smart Investing Starts Here Start SIP with Senores Pharmaceuticals for Steady Growth!
Senores Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 42.6
- PEG Ratio
- 0.6
- Market Cap Cr
- 3,712
- P/B Ratio
- 4.6
- Average True Range
- 31.99
- EPS
- 18.92
- Dividend Yield
- 0
- MACD Signal
- 7.82
- RSI
- 48.1
- MFI
- 47.1
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Technicals
EMA & SMA
Current Price
₹805.95
+
15.9
(2.01%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹815.07
- 50 Day
- ₹798.45
- 100 Day
- ₹761.09
- 200 Day
- ₹687.98
Resistance and Support
792.13
- R3 881.77
- R2 847.28
- R1 826.62
- S1 771.47
- S2 736.98
- S3 716.32
Senores Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-20 | Quarterly Results & Others | To consider other business matters. |
| 2026-01-07 | Others | Inter alia, 1. To consider and evaluate proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group. |
| 2025-11-06 | Quarterly Results | |
| 2025-07-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-05-15 | Audited Results |
Senores Pharmaceuticals F&O
About Senores Pharmaceuticals
- NSE Symbol
- SENORES
- BSE Symbol
- 544319
- Managing Director
- Mr. Swapnil Jatinbhai Shah
- ISIN
- INE0RB801010
Similar Stocks to Senores Pharmaceuticals
Senores Pharmaceuticals FAQs
Senores Pharmaceuticals share price is ₹805 As on 20 January, 2026 | 07:45
The Market Cap of Senores Pharmaceuticals is ₹3711.7 Cr As on 20 January, 2026 | 07:45
The P/E ratio of Senores Pharmaceuticals is 42.6 As on 20 January, 2026 | 07:45
The PB ratio of Senores Pharmaceuticals is 4.6 As on 20 January, 2026 | 07:45
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.